Pain in Parkinson's Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life

Peter Valkovic, Michal Minar, Helena Singliarova, Jan Harsany, Marta Hanakova, Jana Martinkova, Jan Benetin, Peter Valkovic, Michal Minar, Helena Singliarova, Jan Harsany, Marta Hanakova, Jana Martinkova, Jan Benetin

Abstract

Pain is an important and distressing symptom in Parkinson's disease (PD). Our aim was to determine the prevalence of pain, its various types and characteristics, as well as its impact on depression and quality of life (QoL) in patients with PD. How pain differs in early- and advanced-stage PD and male and female PD patients was of special interest. One hundred PD patients on dopaminergic medications had a neurological examination and participated in a structured interview on pain characteristics and completed standardized questionnaires. A total of 76% of the patients had pain. The following types of pain were present: musculoskeletal pain accounted for 41% of the total pain, dystonic pain for 17%, central neuropathic pain for 22%, radicular pain for 27%, and other pains (non-radicular low back pain, arthritic, and visceral pain) made up 24%. One type of pain affected 29% of all the subjects, two types 35%, three types 10%, and four types of pain were reported by 2%. All types of pain were more prevalent in advanced-stage PD subjects than in early-stage PD subjects, except for arthritic pain (subclassified under"other pain"). The frequency and intensity of actual, average, and worst experienced pain were significantly more severe in advanced-stage subjects. PD subjects with general pain and in advanced stages were more depressed and had poorer QoL. Depression correlated with worst pain in the last 24 hours and with pain periodicity (the worst depression score in patients with constant pain). QoL correlated with average pain in the last 7 days. Pain is a frequent problem in PD patients, and it worsens during the course of the disease.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Distribution of pain types in…
Fig 1. Distribution of pain types in PD patients.
Note the higher prevalence of all types of pain except for “other pain” in the advanced stage of PD.
Fig 2. Types of pain in PD…
Fig 2. Types of pain in PD patients.

References

    1. Drobny M, Kurca E. Possible extrapyramidal system degradation in Parkinson's disease. Brain Res Bull 2000. November 1;53:425–430.
    1. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord 1986;1:45–49.
    1. Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, Moretto G, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006. July;77:822–825.
    1. Negre-Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord 2008. July 30;23:1361–1369. 10.1002/mds.22142
    1. Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson's disease. Clin Neurol Neurosurg 2011. January;113:11–13. 10.1016/j.clineuro.2010.07.024
    1. Rana AQ, Kabir A, Jesudasan M, Siddiqui I, Khondker S. Pain in Parkinson's disease: analysis and literature review. Clin Neurol Neurosurg 2013. November;115:2313–2317. 10.1016/j.clineuro.2013.08.022
    1. Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 2008. September;65:1191–1194. 10.1001/archneurol.2008.2
    1. Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson's disease: Prevalence and characteristics. Pain 2009. January;141:173–177.
    1. Silva EG, Viana MA, Quagliato EM. Pain in Parkinson's disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr 2008. March;66:26–29.
    1. Wen HB, Zhang ZX, Wang H, Li L, Chen H, Liu Y, et al. Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue. Parkinsonism Relat Disord 2012. January;18 Suppl 1:S222–S225. 10.1016/S1353-8020(11)70068-2
    1. Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 2006. November;32:462–469.
    1. Wasner G, Deuschl G. Pains in Parkinson disease—many syndromes under one umbrella. Nat Rev Neurol 2012. May;8:284–294. 10.1038/nrneurol.2012.54
    1. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009. May;8:464–474. 10.1016/S1474-4422(09)70068-7
    1. Ford B. Pain in Parkinson's disease. Mov Disord 2010;25 Suppl 1:S98–103. 10.1002/mds.22716
    1. Bernfort L, Gerdle B, Rahmqvist M, Husberg M, Levin LA. Severity of chronic pain in an elderly population in Sweden—Impact on costs and quality of life. Pain 2015. January 14.
    1. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997. June;13:116–137.
    1. Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson's disease: a controlled cross-sectional study. Parkinsonism Relat Disord 2004. March;10:129–136.
    1. Roh JH, Kim BJ, Jang JH, Seo WK, Lee SH, Kim JH, et al. The relationship of pain and health-related quality of life in Korean patients with Parkinson's disease. Acta Neurol Scand 2009. June;119:397–403. 10.1111/j.1600-0404.2008.01114.x
    1. Ehrt U, Larsen JP, Aarsland D. Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry 2009. April;17:269–275.
    1. Santos-Garcia D, Abella-Corral J, Aneiros-Díaz Á, Santos-Canelles H, Llaneza-González MA, Macías-Arribi M [Pain in Parkinson's disease: prevalence, characteristics, associated factors, and relation with other non motor symptoms, quality of life, autonomy, and caregiver burden]. Rev Neurol 2011. April 1;52:385–393.
    1. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140–8.
    1. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529–34.
    1. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010. November 15;25:2649–2653. 10.1002/mds.23429
    1. Cleeland CS. Pain assessment in cancer In: Osoba D, ed. Effect of cancer on quality of life. Boca Raton, Florida: CRC Press, 1991:294–305.
    1. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001. May;92:147–157.
    1. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psychol Health 1997;12:805–814.
    1. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996. December;67:588–597.
    1. Quinn NP, Koller WC, Lang AE, Marsden CD. Painful Parkinson's disease. Lancet 1986. June 14;1:1366–1369.
    1. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, Rascol O, et al. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 2007. October;78:1140–1142.
    1. Broetz D, Eichner M, Gasser T, Weller M, Steinbach JP. Radicular and nonradicular back pain in Parkinson's disease: a controlled study. Mov Disord 2007. April 30;22:853–856.
    1. Dellapina E, Gerdelat-Mas A, Ory-Magne F, Pourcel L, Galitzky M, Calvas F, et al. Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2011. January;26:153–157. 10.1002/mds.23406
    1. Storch A, Schneider CB, Wolz M, Stürwald Y, Nebe A, Odin P, et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 2013. February 26;80:800–809. 10.1212/WNL.0b013e318285c0ed
    1. Muller T, Muhlack S, Woitalla D. Pain perception, pain drug therapy and health status in patients with Parkinson's disease. Neuroepidemiology 2011;37:183–187. 10.1159/000331911
    1. Traub RJ, Ji Y. Sex differences and hormonal modulation of deep tissue pain. Front Neuroendocrinol 2013. October;34:350–366. 10.1016/j.yfrne.2013.07.002
    1. Keogh E, Denford S. Sex differences in perceptions of pain coping strategy usage. Eur J Pain 2009. July;13:629–634. 10.1016/j.ejpain.2008.07.002
    1. Tarsy D, Simon DK. Beating a dead horse: dopamine and Parkinson disease. Neurology 2008. November 11;71:1651–1652. 10.1212/01.wnl.0000339368.54460.68
    1. Barone P. Neurotransmission in Parkinson's disease: beyond dopamine. Eur J Neurol 2010. March;17:364–376. 10.1111/j.1468-1331.2009.02900.x
    1. Gierthmuhlen J, Arning P, Binder A, Herzog J, Deuschl G, Wasner G, et al. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord 2010. July 15;25:1195–1202. 10.1002/mds.23128

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅